Authors
Loading...
Population-based analysis highlights declining second primary malignancies in long-term multiple myeloma survivors, suggesting improved treatment safety.
Lu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: